Skip to content
healthcare.dev

Naproxen

NDC 62207-745, Naproxen Sodium, tablet, from Granules India Ltd.

Product NDC
62207-745
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074140
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM250 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
62207-745-4362207074543100 TABLET in 1 BOTTLE (62207-745-43)
62207-745-4762207074547500 TABLET in 1 BOTTLE (62207-745-47)
62207-745-49622070745491000 TABLET in 1 BOTTLE (62207-745-49)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1f8da545-bcfe-4c22-a9f1-d34108120aa0

Use it

Look up 62207-745 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-745. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.